Cote d'Ivoire vs Guinea: Cause of death, by non-communicable diseases, female
Cote d'Ivoire
37.0%
in 2021
Guinea
37.2%
in 2021
Cote d'Ivoire rank
171st
Guinea rank
169th
Cause of death, by non-communicable diseases, female over time
- Cote d'Ivoire
- Guinea
How they compare
Guinea currently reports 37.2% against 37.0% in Cote d'Ivoire, a difference of 0.2%.
Across all 6 years both countries report, Guinea has been ahead every year.
Cote d'Ivoire ranks 171st and Guinea ranks 169th of 185 countries.
Guinea has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.1% | 24.4% | 11.3% | Guinea |
| 2010s | 30.7% | 35.1% | 4.4% | Guinea |
| 2020s | 36.7% | 37.3% | 0.6% | Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Cote d'Ivoire or Guinea?
- Guinea, at 37.2% against 37.0% in Cote d'Ivoire as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Cote d'Ivoire and Guinea?
- 0.2%, with Guinea ahead.
- How many years of comparable data are there for Cote d'Ivoire and Guinea?
- 6 years are reported by both, from 2000 to 2021.
- How do Cote d'Ivoire and Guinea rank globally for cause of death, by non-communicable diseases, female?
- Cote d'Ivoire ranks 171st and Guinea ranks 169th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.